SC 13G: Sana Biotechnology, Inc.
Ticker: SANA · Form: SC 13G · Filed: 2024-10-22T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Sana Biotechnology, Inc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0002012383-24-001603 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G - Statement of Beneficial Ownership by Certain Investors: SEC Accession No. 0002012383-24-001603 Filing Date 2024-10-22 Accepted 2024-10-22 18:06:47 Documents 1 Document Format Files Seq Description Document Type Size 1 us7995661045_102224.txt SC 13G 12188 Complete submission text file 0002012383-24-001603.txt 13932 Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914 Sana Biotechnology, Inc. (Subject) CIK : 0001770121 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005-92124 | Film No.: 241387311 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5300 BlackRock, Inc. (Filed by) CIK : 0002012383 (see all company filings) EIN. : 991116001 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)